You are currently viewing Global burden Estimate of Human Papillomavirus (GLOBE-HPV)

Global burden Estimate of Human Papillomavirus (GLOBE-HPV)

Project Summary

This is an epidemiological study on Human Papillomavirus (HPV) in Nepal and is the part of Global HPV burden study (GLOBE-HPV). The GLOBE-HPV study aims to gather information on HPV burden and risk factors for HPV infection among girls and women in 8 GAVI-eligible countries, including 5 in Sub-Saharan Africa and 3 countries in South Asia including Nepal. Cervical Cancer (CC) is a preventable cancer. It is the fourth most common cancer among women globally. In Nepal, CC is the most common gynaecological cancer and the leading cause of death due to cancer among Nepalese women. There is limited data from Nepal on the burden of human papillomavirus (HPV- a causative pathogen of CC), and risk factors for HPV infection.

Study Duration

Dec 2022-Dec 2026

Objectives

To investigate the burden of human papillomavirus on girls and women ages 9 to 50 in three South Asian countries and five sub-Saharan African countries that currently have no or limited data on HPV burden.

Outcomes

This study will provide national estimates of the prevalence of HPV among girls and women aged 9-50 years, and information on risk factors for HPV infection among the general population of girls and women. Further, the study will provide information on the incidence of ≥ six-month persistent HPV16/18 among sexually active women aged 18-25 years, Thus, the study will identify a subgroup of the population that continues to be at high risk. It will also characterize the perceptions of gender norms and stigma, and gender-related dynamics that may influence HPV burden. The study also determines the comparability of urine vs self-collected vaginal swabs via HPV genotyping.

Team Members

Principal Investigator(s): Prof. Dr. Rajeev Shrestha, Prof. Dr. Abha Shrestha, Dr. Julia Lynch

Co-Investigator(s): Dr. Dipesh Tamrakar, Mr. Nishan Katuwal

Project Coordinator(s): Ms. Roshna Karki, Mr. Sabin Bikram Shahi

Nepal Lab Lead: Mr. Nishan Katuwal

Molecular Biologist (s): Mr. Nishan Katuwal, Ms. Aastha Shrestha

Research Assistant(s): Ms. Neha Shrestha, Ms. Sona Gautam, Ms. Sanju Thami, Ms. Mamata Maharjan

Supported by: International Vaccine Institute (IVI), South Korea

Collaborating Partners: Centers for Disease Control and Prevention (CDC), United States; Karolinska Institutet (KI), Sweden; London School of Hygiene and Tropical Medicine (LSHTM), UK; BP Koirala Institute of Health Sciences (BPKIHS), Nepal; New Era, Nepal

Publications

  1. The Global Burden Estimation of Human Papillomavirus (GloBE-HPV) Project: Comparison of Detection of High-Risk HPV From First-Void Urine Vs. Self-Collected Cervicovaginal Swabs in South Asia, November 2025, 36th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops Edinburgh, UK, DOI: 10.13140/RG.2.2.36044.94088.

  2. Telele NF, Katuwal N, Kabir F, Rahman S, Shahi SB, Yadav RR, Aziz F, Hossain MA, Hill A, Permatasari I, Lee Y, Cho H, Lee J, You YA, Ahn HS, Park S, Tamrakar D, Pasha A, Alam A, Ejaz M, Nisar MI, Querec TD, Lawal BJ, Choi EM, Watson-Jones D, Basnet P, Shrestha R, Shrestha A, Jehan F, Nahar Q, Hotwani A, Rahman M, Lynch J, Unger ER. Comparison of Self-Collected Vaginal Swabs and First-Void Urine for Detection of Human Papillomavirus in Sexually Active Girls and Women in Three South Asian Countries. medRxiv. Aug 2025. doi:10.1101/2025.08.01.25332560.

  3. Harmonising Laboratory Processes for Global Human Papillomavirus Typing and Burden Estimation, October 2025, 37th International Papillomavirus Conference, Bangkok, Thailand, DOI: 10.13140/RG.2.2.14918.74561.